Royalty Pharma
RPRX
$33.79
Share price
-0.15%
Change (1 day)
-18.22%
Change (1 year)
Categories
Market capitalization of Royalty Pharma (RPRX)
Market cap: $15.14 Billion
As of June 2023 Royalty Pharma has a market cap of $15.14 Billion. This makes Royalty Pharma the world's 1090th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Royalty Pharma from 2020 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $15.14 B | -13.12% |
| 2022 | $17.43 B | 1.85% |
| 2021 | $17.11 B | -11.89% |
| 2020 | $19.42 B |
End of Day market cap according to different sources
On Jun 7th, 2023 the market cap of Royalty Pharma was reported to be:
$15.14 Billion
$15.14 Billion
$20.51 Billion
$15.14 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $176.78 B | 1,067.29% | 🇺🇸 USA |
 Eli Lilly LLY | $414.23 B | 2,635.19% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.99 B | -93.43% | 🇺🇸 USA |